Evidence-Based Medicine Guidelines
Foetal fibronectin testing for reducing the risk of preterm birth
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Foetal Fibronectin Testing for Reducing the Risk of Preterm Birth." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/450322/all/Foetal_fibronectin_testing_for_reducing_the_risk_of_preterm_birth.
Foetal fibronectin testing for reducing the risk of preterm birth. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/450322/all/Foetal_fibronectin_testing_for_reducing_the_risk_of_preterm_birth. Accessed June 1, 2023.
Foetal fibronectin testing for reducing the risk of preterm birth. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/450322/all/Foetal_fibronectin_testing_for_reducing_the_risk_of_preterm_birth
Foetal Fibronectin Testing for Reducing the Risk of Preterm Birth [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 June 01]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/450322/all/Foetal_fibronectin_testing_for_reducing_the_risk_of_preterm_birth.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Foetal fibronectin testing for reducing the risk of preterm birth
ID - 450322
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/450322/all/Foetal_fibronectin_testing_for_reducing_the_risk_of_preterm_birth
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
